Subscribe To
Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...
June 3, 2023, 8:00 pm
Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...
June 3, 2023, 8:00 pm
Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s
– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...
June 3, 2023, 8:00 pm
Japan's demographic struggle deepens as birth rate hits record low in 2022
Japan is the poster child for the aging population syndrome and things don't seem to be getting better ...
June 2, 2023, 5:08 am
Global advanced materials market for water and wastewater treatment to reach us$ 61.7 bn by 2031; membrane was the largest type segment in 2022
Growth in the volume of wastewater owing to the increase in urban population is driving the advanced ma...
June 1, 2023, 9:30 pm
5 stocks to watch from the prospering insurance brokerage industry
Increased demand for insurance products, given an aging population, baby boomers and millennials, and t...
May 31, 2023, 2:01 pm
Lexicon's (lxrx) heart failure drug inpefa gets fda approval
Lexicon's (LXRX) shares rise as it receives FDA approval for Inpefa, a once-daily oral tablet to treat a broad ...
May 30, 2023, 12:10 pm
Calcium channel blockers market predicted to reach $24 billion by 2031, propelled by 5.7% cagr – tmr study
Increase in the prevalence of cardiovascular diseases, a surge in geriatric population, and rise in the...
May 29, 2023, 6:00 pm
Cliff notes: shifting risks and rhetoric
Key insights from the week that was. Events and data have all been offshore this week, with Australia’s single ABS release (April retail sales) due ...
May 26, 2023, 5:23 am
Effector therapeutics reports positive data updates from phase 2 expansion cohorts evaluating zotatifin in patients with er+ metastatic breast cancer at the asco 2023 annual meeting
Partial responses observed in 5 of 19 (26%) evaluable patients treated with zotatifin 0.07 mg/kg combined with fulvestrant and abemaciclib (ZFA triple...
May 25, 2023, 8:50 pm
Leap therapeutics to present updated data from part a of the distinguish study of dkn-01 plus tislelizumab and chemotherapy in gastric cancer patients at the 2023 asco annual meeting
19.5 months median OS in the overall first-line patient population, exceeding current benchmarks Long-t...
May 25, 2023, 5:10 pm
Best buy's comeback is still at play, earnings call for patience
As most retail - and a sizeable wholesale population - businesses struggled for years to compete agains...
May 25, 2023, 10:58 am
Federal realty: fly to quality
Federal Realty Investment Trust is a well-established and high quality REIT with 50+ years of dividend growth. Its properties have extremely strong ...
May 24, 2023, 8:05 am
Not enough babies and too many jobs. why former google ceo schmidt says the ai job risk is overstated.
Worries that AI advances will leave swaths of the global population jobless are being overstated, Eric ...
May 24, 2023, 7:11 am
Water desalination pumps market size projected to reach usd 23.39 billion, at a cagr of 4.47% by 2032 – report by market research future (mrfr)
Water Desalination Pumps Market Growth Boost by Growing population Rate Demand For Clean And Safe Drink...
May 23, 2023, 2:11 pm
Icosavax announces positive topline interim phase 1 results for bivalent vlp vaccine candidate ivx-a12 against rsv and hmpv in older adults
– IVX-A12 induced robust immune responses at Day 28 to both RSV and hMPV in older adults – – IVX-A12 was generally well tolerated with no vaccin...
May 22, 2023, 9:37 pm
Community-focused lenders target gaps in small-business financing
These federally-designated institutions focus their work on historically-disadvantaged populations in a...
May 22, 2023, 10:14 am
3 high-reward stocks riding the healthcare boom
Healthcare stocks are an attractive prospect right now. Nearly 18% of the U.S. GDP went toward healthcare in 2021, which will only continue growing...
May 22, 2023, 7:08 am
Reshoring with robotics & bridging the labor gap
By Drew Anderson Product Analyst Watch the industrial robotics sector – tech progress, population tr...
May 21, 2023, 11:45 am
Better late than never: 3 stocks to buy now that are up more than 20% this year
Alphabet's recent I/O developer conference gave investors plenty to get excited about. Nu Holdings is inviting Latin America's vast unbanked and under...
May 21, 2023, 8:00 am